Ascendis Pharma A/S (ASND)
252.33
+0.38
(+0.15%)
USD |
NASDAQ |
Aug 25, 15:16
Ascendis Pharma 1 Year Total Returns (Daily) : 29.67% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 29.67% |
| August 21, 2026 | 31.37% |
| August 20, 2026 | 32.17% |
| August 19, 2026 | 33.40% |
| August 18, 2026 | 28.22% |
| August 17, 2026 | 24.75% |
| August 14, 2026 | 29.40% |
| August 13, 2026 | 28.86% |
| August 12, 2026 | 30.35% |
| August 11, 2026 | 29.90% |
| August 10, 2026 | 33.49% |
| August 07, 2026 | 34.18% |
| August 06, 2026 | 36.83% |
| August 05, 2026 | 30.88% |
| August 04, 2026 | 32.82% |
| August 03, 2026 | 39.53% |
| July 31, 2026 | 40.58% |
| July 30, 2026 | 50.54% |
| July 29, 2026 | 54.33% |
| July 28, 2026 | 55.00% |
| July 27, 2026 | 51.32% |
| July 24, 2026 | 50.83% |
| July 23, 2026 | 48.50% |
| July 22, 2026 | 52.19% |
| July 21, 2026 | 51.89% |
| Date | Value |
|---|---|
| July 20, 2026 | 48.18% |
| July 17, 2026 | 47.29% |
| July 16, 2026 | 48.12% |
| July 15, 2026 | 53.69% |
| July 14, 2026 | 51.85% |
| July 13, 2026 | 51.59% |
| July 10, 2026 | 53.24% |
| July 09, 2026 | 56.75% |
| July 08, 2026 | 64.82% |
| July 07, 2026 | 51.70% |
| July 06, 2026 | 53.82% |
| July 02, 2026 | 58.58% |
| July 01, 2026 | 55.69% |
| June 30, 2026 | 54.53% |
| June 29, 2026 | 53.12% |
| June 26, 2026 | 50.77% |
| June 25, 2026 | 51.20% |
| June 24, 2026 | 32.89% |
| June 23, 2026 | 35.73% |
| June 22, 2026 | 28.89% |
| June 18, 2026 | 35.22% |
| June 17, 2026 | 33.69% |
| June 16, 2026 | 30.10% |
| June 15, 2026 | 30.73% |
| June 12, 2026 | 27.58% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Evaxion AS | 4.62% |
| Genmab A/S | 33.96% |
| Zealand Pharma A/S | -20.92% |
| Cellectis SA | 11.93% |
| BioMarin Pharmaceutical, Inc. | 11.08% |